Abstract | OBJECTIVE: METHODS: PDAPPV717I transgenic (Tg) mice were randomly divided into 3 model groups (4, 10 and 16 months old mice) and TSG treated (at doses 120 and 240 micromol/kg/d) groups. TSG was administered to some Tg mice with an age range 4-10 months. In untreated 10 months old Tg mice, the TSG was administrated to those falling in the age range 10-16 months. For the control group we adopted the same age and background C57BL/6J mice. The learning-memory ability was measured by applying Morris water maze (MWM) and object recognition test (ORT). RESULTS: In the 4 months old PDAPPV717I Tg mice, the learning- memory deficit was detected. The escape latency in MWM was prolonged, and the discrimination index decreased in ORT. In the 10 months old Tg mice, the learning- memory deficit was aggravated. TSG improved all spatial learning-memory impairment in MWM as well as the object recognition impairment in ORT. In the 16 months old Tg mice, the learning- memory deficit remained to exist but abated a lot. TSG showed significant improvement in learning-memory ability in both MWM and ORT. CONCLUSION: PDAPPV717I transgenic mice with an age range 4-16 months revealed the existence of learning- memory deficit compared with the control group. Tetrahydroxystilbene glucoside not only prevents, i.e. at an early stage, the learning- memory deficit in AD-like model, but also can reverse the learning- memory deficit in the late stage of AD-like model. Thus, TSG could be considered among the future therapeutic drugs indicated for the treatment of AD.
|
Authors | Lan Zhang, Ying Xing, Cui-Fei Ye, Hou-Xi Ai, Hai-Feng Wei, Lin Li |
Journal | Behavioural brain research
(Behav Brain Res)
Vol. 173
Issue 2
Pg. 246-54
(Oct 16 2006)
ISSN: 0166-4328 [Print] Netherlands |
PMID | 16901557
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Amyloid beta-Protein Precursor
- Glucosides
- Stilbenes
- 2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside
|
Topics |
- Age Factors
- Aging
- Alzheimer Disease
(complications, genetics)
- Amyloid beta-Protein Precursor
(genetics)
- Analysis of Variance
- Animals
- Disease Models, Animal
- Glucosides
(therapeutic use)
- Learning Disabilities
(drug therapy, etiology, genetics)
- Maze Learning
(drug effects)
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Pattern Recognition, Visual
(drug effects)
- Stilbenes
(therapeutic use)
|